Aromasin 25 | Exemestane | for Breast Cancer Treatment

Introduction of Aromasin 25

Aromasin 25 mg is a prescription medication that contains Exemestane, a steroidal aromatase inhibitor used in the treatment of estrogen receptor-positive breast cancer in postmenopausal women. It works by significantly lowering estrogen levels, a hormone that fuels the growth of certain types of breast tumors.

Aromasin is commonly prescribed as part of adjuvant therapy (treatment given after the primary treatment to lower the chance of cancer returning) or to manage advanced or metastatic breast cancer when the cancer has progressed after treatment with other hormone therapies such as tamoxifen.

✅ Key Benefits

• Treats hormone receptor-positive breast cancer in postmenopausal women
  
  

• Reduces estrogen levels to help slow or stop tumor growth
  
  

• Used after tamoxifen treatment to prevent cancer recurrence
  
  

• Effective in both early and advanced stages of breast cancer
  
  

• Supports long-term remission when used as part of a complete treatment plan
  
  

✅ Possible Side Effects

Common side effects:

• Hot flashes
  
  

• Fatigue
  
  

• Joint pain or stiffness
  
  

• Nausea
  
  

• Headache
  
  

• Sweating
  
  

• Osteoporosis with long-term use
  
  

✅ Precautions & Warnings

• Not recommended for premenopausal women or during pregnancy
  
  

• May reduce bone mineral density – monitor for signs of osteoporosis
  
  

• Use with caution in individuals with liver or kidney issues
  
  

• Avoid using with estrogen-containing medications or HRT
  
  

• Inform your healthcare provider about all medications and supplements
  
  

✅ Storage Instructions

• Store at room temperature (20–25°C or 68–77°F)
  
  

• Keep away from direct light, heat, and moisture
  
  

• Store in the original packaging
  
  

• Keep out of reach of children
  
  

Aromasin 25 mg is a powerful hormonal therapy for the treatment of estrogen-dependent breast cancer in postmenopausal women. As a steroidal aromatase inhibitor, it effectively lowers estrogen levels, helping to prevent tumor growth and recurrence. Aromasin is often used after tamoxifen or as a first-line option in metastatic settings, offering hope for long-term remission and improved outcomes when used as part of a comprehensive treatment plan.